Optomed Oyj Stock price

Equities

OPTOMED

FI4000410881

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Helsinki 12:29:33 2024-03-28 pm EDT 5-day change 1st Jan Change
3.95 EUR -0.75% Intraday chart for Optomed Oyj -8.14% +6.33%
Sales 2024 * 16.79M 18.11M Sales 2025 * 25.35M 27.35M Capitalization 70.22M 75.76M
Net income 2024 * -3M -3.24M Net income 2025 * -2M -2.16M EV / Sales 2024 * 4.24 x
Net Debt 2024 * 965K 1.04M Net Debt 2025 * 4.58M 4.94M EV / Sales 2025 * 2.95 x
P/E ratio 2024 *
-18 x
P/E ratio 2025 *
-25.5 x
Employees 114
Yield 2024 *
-
Yield 2025 *
-
Free-Float 87.31%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.75%
1 week-8.14%
Current month+12.86%
1 month+19.52%
3 months+8.52%
6 months+48.22%
Current year+6.33%
More quotes
1 week
3.86
Extreme 3.86
4.14
1 month
3.30
Extreme 3.3
4.55
Current year
3.26
Extreme 3.26
4.55
1 year
2.31
Extreme 2.305
4.55
3 years
2.02
Extreme 2.015
19.15
5 years
2.02
Extreme 2.015
19.15
10 years
2.02
Extreme 2.015
19.15
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 23-09-30
Director of Finance/CFO 40 18-12-31
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Chairman 66 05-12-31
Director/Board Member 72 18-12-31
Director/Board Member 68 18-12-31
More insiders
Date Price Change Volume
24-03-28 3.95 -0.75% 19,563
24-03-27 3.98 0.00% 29,948
24-03-26 3.98 -0.25% 32,684
24-03-25 3.99 -0.75% 25,730
24-03-22 4.02 -5.52% 62,753

Delayed Quote Nasdaq Helsinki, March 28, 2024 at 12:29 pm EDT

More quotes
Optomed Oyj is a Finland-based medical technology company and a producer of handheld fundus cameras globally. The Group's Parent Company, Optomed Oyj, is responsible for, among other things, the management of the Group as well as finance and accounting functions, human resources, legal affairs and corporate communication. The Group's business is managed through two reportable segments: Devices and Software. The Devices segment develops, commercializes and manufactures easy-to-use and affordable handheld fundus cameras. The Software segment develops and sells screening software for diabetic retinopathy and cancer screening for healthcare organizations. The Optomed Group consists of the parent company Optomed Oyj and four subsidiaries in Finland, China, the USA and Hong Kong.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
3.95 EUR
Average target price
5.8 EUR
Spread / Average Target
+46.84%
Consensus
  1. Stock
  2. Equities
  3. Stock Optomed Oyj - Nasdaq Helsinki